Erratum
In the paper by Kerwin, D, Abdelnour, C, Caramelli, P, et al. (“Alzheimer's disease diagnosis and management: Perspectives from around the world.” Alzheimer's Dement. 2022; 14:e12334. https://doi.org/10.1002/dad2.12334), five errors occurred in the preparation of the paper for publication, requiring the following correction.
In the initial publication of this article, Table 2 should not include an asterisk after “Nigeria” in the country column.
Second, reference number 8 should be updated to: France Alzheimer. Personnes malades jeunes: Les oubliées d'Alzheimer. https://www.francealzheimer.org/personnes‐malades‐jeunes‐lesoubliees‐dalzheimer/. Accessed 20 May 2021.
Third, reference number 18 should be updated to: Boada M, Rodrigo A, Jessen F, et al. Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project. Alzheimers Dement. 2022;18:1119‐1127.
Fourth, reference number 19 should be updated to: Balasa M, Ripoll GP, Guix JLM, et al. Guies clíniques dt'us debiomarcadors de malaltia d'Alzheimer en el líquid cefalorraquidien l'avaluació de pacients amb deteriorament cognitiu. https://www.academia.cat/files/204‐3749‐FITXER/GUIESCLNIQUESUSBIOMARCADORSJULIOL2015DEFINITIVA.pdf. Accessed 22 September 2021.
Fifth, reference number 26 should be updated to: Andreasen N, Blennow K, Zetterberg H. Neuroinflammation screening in immunotherapy trials against Alzheimer's disease. Int J Alzheimers Dis. 2010;638379.
The authors regret these errors.